MichaelBrinesMDPhD
Endocrinology • Guilford, CTDiabetes, Lipid Metabolism
Chief Scientific and Medical Officer
Dr. Brines is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2488 Boston Post Rd
Guilford, CT 06437Phone+1 203-204-6130
Education & Training
Yale-New Haven Medical CenterResidency, Internal Medicine, 1984 - 1986
Yale School of MedicineClass of 1983
Certifications & Licensure
CT State Medical License 1986 - 2020
Publications & Presentations
PubMed
- 1 citationsThe erythropoietin-derived peptide ARA 284 reduces tissue wasting and improves survival in a rat model of cancer cachexia.Sandra Palus, Yulia Elkina, Tanja Braun, Stephan von Haehling, Wolfram Döhner
Journal of Cachexia, Sarcopenia and Muscle. 2022-08-01 - 2 citationsFamotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm.Huan Yang, Sam J George, Dane A Thompson, Harold A Silverman, Téa Tsaava
Molecular Medicine. 2022-05-16 - 14 citationsFamotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm.Huan Yang, Sam J George, Dane Thompson, Harold A Silverman, Tea Tsaava
Research Square. 2022-04-11
Press Mentions
ARA 290 Obtains European Union Orphan Drug Designation for Prevention of Graft Loss in Pancreatic Islet TransplantationNovember 28th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
